VahatiCor Appoints Harry D. Rowland, Ph.D., as Chief Executive Officer
PRIVATEMay 18, 2026
Position
Chief Executive Officer
Company
VahatiCor
Harry D. Rowland, Ph.D.
Santa ClaraBiotechnologyHealth CareMedicalTherapeutics
Description
VahatiCor, Inc. has announced the appointment of Harry D. Rowland, Ph.D., as Chief Executive Officer
Company Information
Company
VahatiCor
Location
Santa Clara, California, United States
About
VahatiCor is a medtech company dedicated to transforming cardiac care for Coronary Microvascular Dysfunction (CMD). They are focused on developing innovative therapies, particularly the A-FLUX Reducer System®, which aims to enhance myocardial perfusion and relieve symptoms of angina for millions affected by CMD. The company is currently advancing clinical studies and preparing for pivotal trials to bring their breakthrough therapies to market. Their mission is to improve the quality of life for patients suffering from this often overlooked medical condition.
Fundz sees it the moment VahatiCor changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.